^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CXCL13 overexpression

i
Other names: CXCL13, ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13, Chemokine (C-X-C motif) ligand 13
Entrez ID:
Related biomarkers:
3ms
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma. (PubMed, Cancer Med)
These findings imply that serum CXCL13 holds diagnostic and prognostic value, showing promise as a novel biomarker for OSCC.
Journal
|
CD8 (cluster of differentiation 8) • CXCL13 (Chemokine (C-X-C motif) ligand 13)
|
CD8 expression • CXCL13 expression • CXCL13 overexpression
9ms
Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer. (PubMed, Nat Commun)
Finally, we delineate the distinct features of malignant epithelial cells in primary and recurrent tumors, providing a theoretical foundation for the precise selection of targeted therapy for tumors at different stages. In summary, the current study offers a comprehensive landscape and deep insight into epithelial and microenvironmental reprogramming throughout initiation, progression, lymph node metastasis and recurrence of head and neck squamous cell carcinoma.
Journal
|
CD8 (cluster of differentiation 8) • SPP1 (Secreted Phosphoprotein 1) • CXCL13 (Chemokine (C-X-C motif) ligand 13) • POSTN (Periostin)
|
CXCL13 expression • CXCL13 overexpression
10ms
Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia. (PubMed, Ann Hematol)
Our study concludes that serum CXCL13 levels decrease in WM patients treated with various regimens and correlate with treatment response. Detecting serum CXCL13 at baseline or after treatment help in predicting prognosis.
Journal
|
B2M (Beta-2-microglobulin) • CXCL13 (Chemokine (C-X-C motif) ligand 13)
|
CXCL13 overexpression